ABSTRACT
Renal sympathetic denervation has shown promise in treating hypertension resistant to drug therapy. This procedure lowers blood pressure via targeted attenuation of renal sympathetic tone, and it has a favorable safety profile. But although there is reason for cautious optimism, we should keep in mind that the mechanisms of hypertension are complex and multifactorial, and further study of this novel therapy and its long-term effects is needed.
Footnotes
↵* Dr. Shishehbor has disclosed that he has served as a consultant for Medtronic.
- Copyright © 2012 The Cleveland Clinic Foundation. All Rights Reserved.